Picture of Aethlon Medical logo

AEMD — Aethlon Medical News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapSucker Stock

Aethlon Medical Inc expected to post a loss of 20  cents a share - Earnings Preview

* Aethlon Medical Inc  AEMD.OQ   AEMD.O  is expected to show a
rise in quarterly revenue when it reports results on June 23 .
* The San Diego, California-based company is expected to report 
 a 80.4% increase in revenue to $373.33 thousand from $207
thousand a year ago, according to the mean estimate from 3
analysts, based on Refinitiv data. 
​* Refinitiv's mean analyst estimate for Aethlon Medical Inc is
for a loss of 20 cents per share. For the same quarter last
year, the company reported a loss of 22 cents per share.
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
* The mean earnings estimate of analysts was unchanged in the
last three months. ​
* Wall Street's median 12-month price target for Aethlon Medical
Inc is $8​, about 34.8% above​ its last closing price
of $5.22. ​​​
* Previous quarterly performance (using preferred earnings
measure in US dollars). ​
 QUARTER       STARMINE    REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        SMARTESTIM  IBES                 MET,    SE %
               ATE®        ESTIMATE             MISSED  
 Dec. 31 2020  -0.17       -0.16      -0.20     Missed  -21.2
 Sep. 30 2020  -0.12       -0.12      -0.15     Missed  -25
                                                        ​
 Mar. 31 2020  -0.16       -0.16      -0.22     Missed  -36.2
 Dec.          -1.03​      -1.03      -0.30     Beat    70.9​
 31​ 2019​                                              
 Sep. 30 2019  -1.10       -1.10      -1.29     Missed  -17.3​
 Jun. 30 2019  -1.20       -1.20      -1.35     Missed  -12.5
 Mar. 31 2019              -1.05      -1.35     Missed  -28.6
 This summary was machine generated June 21 at 20:15 GMT.  All
figures in US dollars unless otherwise stated

Recent news on Aethlon Medical

See all news